These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12653952)

  • 1. Expression of cyclin A and topoisomerase IIalpha of oligodendrogliomas is correlated with tumour grade, MIB-1 labelling index and survival.
    Park SH; Suh YL
    Histopathology; 2003 Apr; 42(4):395-402. PubMed ID: 12653952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/Kip-1 protein immunoexpression in oligodendrogliomas.
    Korshunov A; Golanov A
    Arch Pathol Lab Med; 2001 Jul; 125(7):892-8. PubMed ID: 11419973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
    Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
    J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
    Korshunov A; Shishkina L; Golanov A
    Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery.
    Winther TL; Torp SH
    PLoS One; 2017; 12(3):e0172316. PubMed ID: 28301542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitosin and DNA topoisomerase IIalpha: two novel proliferation markers in the prognostication of diffuse astrocytoma patient survival.
    Korkolopoulou P; Patsouris E; Konstantinidou AE; Christodoulou P; Thomas-Tsagli E; Kouzelis K; Angelidakis D; Rologis D; Davaris P
    Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):207-14. PubMed ID: 11556747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High topoisomerase IIalpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas.
    Miettinen HE; Järvinen TA; Kellner U; Kauraniemi P; Parwaresch R; Rantala I; Kalimo H; Paljärvi L; Isola J; Haapasalo H
    Neuropathol Appl Neurobiol; 2000 Dec; 26(6):504-12. PubMed ID: 11123716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas.
    Michaud K; de Tayrac M; D'Astous M; Paquet C; Gould PV; Saikali S
    PLoS One; 2018; 13(2):e0193213. PubMed ID: 29489901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma.
    Deininger MH; Weller M; Streffer J; Meyermann R
    Cancer; 1999 Nov; 86(9):1832-9. PubMed ID: 10547558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical markers for prognosis of oligodendroglial neoplasms.
    Korshunov A; Golanov A; Sycheva R
    J Neurooncol; 2002 Jul; 58(3):237-53. PubMed ID: 12187958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.
    Kros JM; Hop WC; Godschalk JJ; Krishnadath KK
    Cancer; 1996 Sep; 78(5):1107-13. PubMed ID: 8780550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic importance of survivin, Ki-67, and topoisomerase IIα in ovarian carcinoma.
    Kucukgoz Gulec U; Gumurdulu D; Guzel AB; Paydas S; Seydaoglu G; Acikalin A; Khatib G; Zeren H; Vardar MA; Altintas A
    Arch Gynecol Obstet; 2014 Feb; 289(2):393-8. PubMed ID: 23974278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase II alpha as a reliable proliferation marker in meningiomas.
    Roessler K; Gatterbauer B; Kitz K
    Neurol Res; 2002 Apr; 24(3):241-3. PubMed ID: 11958416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 expression in gliomas.
    Cavalla P; Dutto A; Piva R; Richiardi P; Grosso R; Schiffer D
    Acta Neuropathol; 1998 Feb; 95(2):131-5. PubMed ID: 9498046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival.
    Varlet P; Guillamo JS; Nataf F; Koziak M; Beuvon F; Daumas-Duport C
    Neuropathol Appl Neurobiol; 2000 Aug; 26(4):379-89. PubMed ID: 10931372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation, C-myc, and cyclin D1 expression in diffuse alveolar damage: potential roles in pathogenesis and implications for prognosis.
    Adamson A; Perkins S; Brambilla E; Tripp S; Holden J; Travis W; Guinee D
    Hum Pathol; 1999 Sep; 30(9):1050-7. PubMed ID: 10492039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of cell cycle regulatory proteins in oligodendroglial tumors.
    Kamiya M; Nakazato Y
    Clin Neuropathol; 2002; 21(2):52-65. PubMed ID: 12005253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
    Heesters MA; Koudstaal J; Go KG; Molenaar WM
    J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas.
    Coons SW; Johnson PC; Pearl DK
    Neurosurgery; 1997 Oct; 41(4):878-84; discussion 884-5. PubMed ID: 9316050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas.
    Majumdar K; Radotra BD; Vasishta RK; Pathak A
    Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.